BECN1 and neoplasm: Here, to avoid the problems of multiple cutpoint selection and get an unbiased Beclin 1 cutoff point for clinical implication, we used ROC curve analysis as an alternative method in the selection and validation of cut-off scores to determine the most clinically relevant threshold for immunohistochemical tumour positivity.